139 related articles for article (PubMed ID: 38211534)
1. Subcellular localization and ER-mediated cytotoxic function of α1A and α1ACT in spinocerebellar ataxia type 6.
Wang D; Honda S; Shin MK; Watase K; Mizusawa H; Ishikawa K; Shimizu S
Biochem Biophys Res Commun; 2024 Feb; 695():149481. PubMed ID: 38211534
[TBL] [Abstract][Full Text] [Related]
2. Bicistronic CACNA1A Gene Expression in Neurons Derived from Spinocerebellar Ataxia Type 6 Patient-Induced Pluripotent Stem Cells.
Bavassano C; Eigentler A; Stanika R; Obermair GJ; Boesch S; Dechant G; Nat R
Stem Cells Dev; 2017 Nov; 26(22):1612-1625. PubMed ID: 28946818
[TBL] [Abstract][Full Text] [Related]
3. DnaJ-1 and karyopherin α3 suppress degeneration in a new Drosophila model of Spinocerebellar Ataxia Type 6.
Tsou WL; Hosking RR; Burr AA; Sutton JR; Ouyang M; Du X; Gomez CM; Todi SV
Hum Mol Genet; 2015 Aug; 24(15):4385-96. PubMed ID: 25954029
[TBL] [Abstract][Full Text] [Related]
4. Second cistron in CACNA1A gene encodes a transcription factor mediating cerebellar development and SCA6.
Du X; Wang J; Zhu H; Rinaldo L; Lamar KM; Palmenberg AC; Hansel C; Gomez CM
Cell; 2013 Jul; 154(1):118-33. PubMed ID: 23827678
[TBL] [Abstract][Full Text] [Related]
5. Polyglutamine length-dependent toxicity from α1ACT in Drosophila models of spinocerebellar ataxia type 6.
Tsou WL; Qiblawi SH; Hosking RR; Gomez CM; Todi SV
Biol Open; 2016 Dec; 5(12):1770-1775. PubMed ID: 27979829
[TBL] [Abstract][Full Text] [Related]
6. An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron.
Miyazaki Y; Du X; Muramatsu S; Gomez CM
Sci Transl Med; 2016 Jul; 8(347):347ra94. PubMed ID: 27412786
[TBL] [Abstract][Full Text] [Related]
7. Targeting the CACNA1A IRES as a Treatment for Spinocerebellar Ataxia Type 6.
Pastor PDH; Du X; Fazal S; Davies AN; Gomez CM
Cerebellum; 2018 Feb; 17(1):72-77. PubMed ID: 29374372
[TBL] [Abstract][Full Text] [Related]
8. Spinocerebellar [corrected] Ataxia Type 6: Molecular Mechanisms and Calcium Channel Genetics.
Du X; Gomez CM
Adv Exp Med Biol; 2018; 1049():147-173. PubMed ID: 29427102
[TBL] [Abstract][Full Text] [Related]
9. Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset.
Pulst SM; Santos N; Wang D; Yang H; Huynh D; Velazquez L; Figueroa KP
Brain; 2005 Oct; 128(Pt 10):2297-303. PubMed ID: 16000334
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of spinocerebellar ataxia type 6.
Kordasiewicz HB; Gomez CM
Neurotherapeutics; 2007 Apr; 4(2):285-94. PubMed ID: 17395139
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic cleavage and cellular toxicity of the human alpha1A calcium channel in spinocerebellar ataxia type 6.
Kubodera T; Yokota T; Ohwada K; Ishikawa K; Miura H; Matsuoka T; Mizusawa H
Neurosci Lett; 2003 Apr; 341(1):74-8. PubMed ID: 12676347
[TBL] [Abstract][Full Text] [Related]
12. The carboxy-terminal fragment of alpha(1A) calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cells.
Ishiguro T; Ishikawa K; Takahashi M; Obayashi M; Amino T; Sato N; Sakamoto M; Fujigasaki H; Tsuruta F; Dolmetsch R; Arai T; Sasaki H; Nagashima K; Kato T; Yamada M; Takahashi H; Hashizume Y; Mizusawa H
Acta Neuropathol; 2010 Apr; 119(4):447-64. PubMed ID: 20043227
[TBL] [Abstract][Full Text] [Related]
13. Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia.
Kahle JJ; Gulbahce N; Shaw CA; Lim J; Hill DE; Barabási AL; Zoghbi HY
Hum Mol Genet; 2011 Feb; 20(3):510-27. PubMed ID: 21078624
[TBL] [Abstract][Full Text] [Related]
14. Splice isoform-specific suppression of the Cav2.1 variant underlying spinocerebellar ataxia type 6.
Tsou WL; Soong BW; Paulson HL; Rodríguez-Lebrón E
Neurobiol Dis; 2011 Sep; 43(3):533-42. PubMed ID: 21550405
[TBL] [Abstract][Full Text] [Related]
15. Loss of Flocculus Purkinje Cell Firing Precision Leads to Impaired Gaze Stabilization in a Mouse Model of Spinocerebellar Ataxia Type 6 (SCA6).
Chang HHV; Cook AA; Watt AJ; Cullen KE
Cells; 2022 Sep; 11(17):. PubMed ID: 36078147
[TBL] [Abstract][Full Text] [Related]
16. [Molecular physiopathology of the spinocerebellar ataxia type 6 (SCA6)].
Cervantes-Kardasch VH; García-Martínez E
Rev Invest Clin; 2004; 56(3):368-74. PubMed ID: 15612520
[TBL] [Abstract][Full Text] [Related]
17. The P/Q-type voltage-dependent calcium channel as pharmacological target in spinocerebellar ataxia type 6: gabapentin and pregabalin may be of therapeutic benefit.
Gazulla J; Tintoré MA
Med Hypotheses; 2007; 68(1):131-6. PubMed ID: 16899342
[TBL] [Abstract][Full Text] [Related]
18. Spinocerebellar ataxia type 6 protein aggregates cause deficits in motor learning and cerebellar plasticity.
Mark MD; Krause M; Boele HJ; Kruse W; Pollok S; Kuner T; Dalkara D; Koekkoek S; De Zeeuw CI; Herlitze S
J Neurosci; 2015 Jun; 35(23):8882-95. PubMed ID: 26063920
[TBL] [Abstract][Full Text] [Related]
19. Reduced brain-derived neurotrophic factor (BDNF) mRNA expression and presence of BDNF-immunoreactive granules in the spinocerebellar ataxia type 6 (SCA6) cerebellum.
Takahashi M; Ishikawa K; Sato N; Obayashi M; Niimi Y; Ishiguro T; Yamada M; Toyoshima Y; Takahashi H; Kato T; Takao M; Murayama S; Mori O; Eishi Y; Mizusawa H
Neuropathology; 2012 Dec; 32(6):595-603. PubMed ID: 22393909
[TBL] [Abstract][Full Text] [Related]
20. Spinocerebellar ataxia type 6.
Solodkin A; Gomez CM
Handb Clin Neurol; 2012; 103():461-73. PubMed ID: 21827907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
